Linkedin
See it in Action
Linkedin
See it in Action

Metabolomics, an emerging clinical modality, enabling precision, personalized medicine

Leave a Comment / By /
[featured_image]
Download is available until [expire_date]
  • Version
  • Download 0
  • File Size 68 KB
  • File Count 1
  • Create Date July 23, 2024
  • Last Updated July 23, 2024

Metabolomics, an emerging clinical modality, enabling precision, personalized medicine

Article

  Publications and Press  

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to Top
video-thumb

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.
  • Background in medicinal chemistry
  • Built and headed the life sciences department at numares AG
  • Pioneered NMR-based metabolic profiling
  • Successfully implemented 30+ R&D projects for analytical methods, software and systems

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.
  • Background in Biophysics, computer sciences and NMR. Several patents in this field.
  • Member of the board of lipofit GmbH and numares AG. Establishing internationalization.
  • Co-founded lifespin GmbH in 2017. Setting up company structures.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.
  • Plasma physics, MPI Garching
  • In 2004 he co-founded LipoFIT GmbH, served as its manager, transforming it into numares AG—growing the company into an international operation
  • Co-founded lifespin GmbH in 2017

Dr. Ali Tinazli

CEO, lifespin GmbH
Linkedin Envelope

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).

  • Built HP’s global healthcare strategy
  • Commercialized first IVD product for billionaire-funded Fluxergy
  • Board member (e.g. Edico Genome acquired by Illumina)